Society News Archive

28 June 2015
New ICRP Report 128 on Radiation Dose to Patients

The International Commission on Radiological Protection (ICRP) has published ICRP Publication 128, Radiation Dose to Patients From Radiopharmaceuticals: A Compendium of Current Information Related to Frequently Used Substances.

The abstract for the report reads as follows:

This report provides a compendium of current information relating to radiation dose to patients, including biokinetic models, biokinetic data, dose coefficients for organ and tissue absorbed doses, and effective dose for major radiopharmaceuticals based on the radiation protection guidance given in Publication 60 (ICRP, 1991). These data were mainly compiled from Publications 53 , 80, and 106 (ICRP, 1987, 1998, 2008), and related amendments and corrections. This report also includes new information for 82Rb-chloride, iodide (123I, 124I, 125I, and 131I) and 123I labelled 2.-carbomethoxy 3.-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (FPCIT).

The coefficients tabulated in this publication will be superseded in due course by values calculated using new International Commission on Radiation Units and Measurements/International Commission on Radiological Protection adult and paediatric reference phantoms and Publication 103 methodology. The data presented in this report are intended for diagnostic nuclear medicine and not for therapeutic applications.

The report is available for purchase in print or pdf format.